RodabeNAmariaMD

Oncology • Houston, TX

Physician

Join to view full profile

Dr. Amaria is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Amaria's full profile

Already have an account?

Office
1515 Holcombe Blvd
Houston, TX 77030
Phone+1 713-792-6161

Education & Training

University of ColoradoFellowship, Hematology and Medical Oncology, 2010 - 2013
University of ColoradoResidency, Internal Medicine, 2006 - 2009
University of Colorado School of Medicine Anschutz Medical CampusClass of 2006

Certifications & Licensure

FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2026
WA State Medical License 2023 - 2026
AL State Medical License 2024 - 2025
GA State Medical License 2023 - 2025
LA State Medical License 2023 - 2025
MS State Medical License 2023 - 2025
OK State Medical License 2020 - 2025
TN State Medical License 2023 - 2025
TX State Medical License 2013 - 2025
CO State Medical License 2009 - 2019
American Board of Internal Medicine Medical Oncology
Join now to see all

Clinical Trials

Neoadjuvant and Adjuvant Checkpoint Blockade Start of enrollment: 2016 Feb 02
Completed
Phase 2
Dabrafenib and Trametinib Before and After Surgery in Treating Patients With Stage IIIB-C Melanoma With BRAF V600 Mutation Start of enrollment: 2014 Oct 22
Active, not recruiting
Phase 2
Roles: Contact, Principal Investigator
Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma Start of enrollment: 2022 Sep 07
Active, not recruiting
Phase 1
Roles: Contact, Principal Investigator
A Phase 1/2 Study of KSQ-001EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate the SOCS1 Gene, in Patients With Select Advanced Solid Tumors Start of enrollment: 2024 Jan 31
Recruiting
Phase 1, Phase 2
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Durable local control with hypofractionated radiation therapy for unresectable or metastatic melanoma.
Sydney A Keatts, Aya F Salem, David M Swanson, Ahsan S Farooqi, Andrew J Bishop
Clinical and Translational Radiation Oncology. 2024-11-01
Survival and treatment outcomes in patients with leptomeningeal disease from metastatic melanoma.
Chantal Saberian, Denái R Milton, Julie Simon, Rodabe N Amaria, Adi Diab
Neuro-Oncology Practice. 2024-08-01
Project Optimus Elicits the "Holistic" Benefits of PK/PD Modeling of Immunotherapy.
Mathangi Gopalakrishnan, Rodabe N Amaria
Clinical Cancer Research. 2024-07-15

Press Mentions

Breakthrough Study Shows Promise for mRNA Cancer VaccinesApril 17th, 2023
In What Could Be a 'Big Shift' for Cancer Treatment, mRNA Vaccine Shows Promise Against MelanomaApril 16th, 2023
FDA Gives MD Anderson the Green Light to Test Skin Cancer Treatment on HumansAugust 16th, 2022
Join now to see all